Potassium voltage-gated channel subfamily C member 4 (Kv3.4) (Kv3.4)

Potassium voltage-gated channel subfamily C member 4 (Kv3.4) is a specialized ion channel encoded by the KCNC4 gene, primarily found in the central and peripheral nervous systems (UniProt: P48544). It belongs to the Shaw-related subfamily and is characterized by its unique ability to activate and deactivate rapidly at high voltages, which is essential for maintaining high-frequency firing in neurons (PubMed: 10751448). The channel is prominently expressed at presynaptic terminals, where it plays a vital role in repolarizing the membrane and regulating the duration of neurotransmitter release (PubMed: 22414369). In clinical research, Kv3.4 has been identified as a significant factor in the early pathogenesis of Alzheimer's disease, with its upregulation in the hippocampus and cortex linked to amyloid-beta-induced synaptic dysfunction (PubMed: 15159487). Furthermore, Kv3.4 is implicated in the transmission of chronic and neuropathic pain, making it a promising target for novel analgesic therapies (PubMed: 22414369). It also appears to play a role in cell cycle regulation in certain cancers, such as oral squamous cell carcinoma (PubMed: 25605104). Pharmacological targeting of Kv3.4 often involves peptide toxins like Blood-depressing substance I (BDS-I), which selectively block the channel to modulate neuronal excitability (IUPHAR/BPS Guide to Pharmacology). However, the high degree of structural similarity among Kv3 family members poses a significant challenge for developing highly selective small-molecule inhibitors without causing off-target effects like seizures or cognitive deficits.

Other names

KCNC4Shaw-related subfamily member 4Voltage-gated potassium channel subunit Kv3.4KSHIIIC

Blockade of the ion-conducting pore to inhibit potassium efflux and prolong action potential duration (PubMed: 10751448); modulation of channel gating kinetics to restore normal neuronal firing patterns (PubMed: 22414369).